At this time, posts about Samsung Pharmaceutical are rapidly increasing on portals and stock communities. Samsung Pharmaceutical is known as a leading pharmaceutical company specializing in over-the-counter drugs such as Casse Myungsoo.


As of 12:30 PM on the 30th, Samsung Pharmaceutical's stock price remains at 6,120 KRW, the same as the previous day, with a trading volume of 3,248,275 shares, which is about 11.49% of the 5-day average trading volume. On December 29th, Samsung Pharmaceutical was a market topic due to the news of completing Phase 3 trials for a pancreatic cancer treatment, which led to a strong performance.


In addition to Samsung Pharmaceutical, posts by investors are also surging for Sambutogeon (001470), LG Electronics Preferred (066575), and Gukjeon Pharmaceuticals (307750).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing